Biomineralog of lung tumors.


On behalf of the Journal of Cancer Immunology and Therapy, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been ten long years we have started the Journal, now we are celebrating the Two Years Anniversary and we are privileged to welcome Analytical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Cancer Immunology and Therapy.

The study was devoted to determining whether cancer tissues in lungs are mineralized or not. Moreover, the author aimed to find the answer for the following question: Can mineralization of tissue lead to formation of cancerous tumors, or do cancer tissues produce substances necessary for lung mineralization? Perhaps both phenomena are possible? Studies were performed using classic mineralogical methods on thin sections of cancer tissues prepared with the use of a microtome. Obtained results confirmed the presence of trace mineralization in cancer tissues. It was represented by two types of mineralization, i.e. hidden and apparent mineralization. Both types are probably factors creating deformations of DNA and leading to formation of cancer. This hypothesis has to be confirmed by experimental studies.

In conclusion, one can hypothesize that both hidden and apparent tissue mineralization, including the so-called calcification, may promote structural DNA defects arising during the division of chromosomes in the process of cell multiplication. The cell division environment with an abnormal content of elements (too low or too high mineralization) can promote deformations of the DNA segment which is responsible for the rate of mitotic divisions. Thus, the mineralization of tissues and body fluids (caused by both external and internal factors) may promote the formation of tumors. Confirmation of this theory requires further research, including experimental research; this research and publication are dedicated to my mother, who died of lung cancer.

We publish the article related to the effects of cancer, Treatment, outcomes of the treatment. We invite different types of science communications including original research article, systematic reviews, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

Authors can submit their manuscripts as an email attachment to the following e-mail id 

Shelley Brown
Editorial Team
Journal of Cancer Immunology and Therapy
Whats App: +1-97-333-4405